Manual of Cardiovascular Disease in Women

Angela Maas, MD PhD, is a clinical cardiologist since more than 30 years and has developed a main interest in heart disease in women over the past decades. She established the first outpatient clinic for women in the Netherlands in 2003. She was appointed as professor in cardiology for women at the Radboudumc in Nijmegen in 2012. Her main interests are the early identification of women at increased CV risk and symptom evaluation in women at middle-age. She has received many awards such as by the Dutch Society of female physicians (2010), the Radboud University (2014) and was knighted by the King in 2017. She is currently one of the most influential female doctors in Dutch healthcare and was the 2020/21 Women’s representative of the Dutch Government to the United Nations. From May 2022 onwards she primarily dedicates her work to research, educational activities and advisory boards. Eva Gerdts, MD PhD, is a cardiologist since 1994. Her main interest has been how hypertension contributes to sex differences in common cardiac diseases, including hypertensive heart disease, coronary artery disease, atrial fibrillation and aortic valve stenosis. She has worked as a clinical cardiologist at Haukeland University Hospital since 1997. She was appointed professor of cardiology at the University of Bergen (UiB) in 2006. Based on her work, a dedicated Center for Research on Cardiac Disease in Women, which she chairs, was established at the UiB in 2020. She has extensive international research experience, including as postdoctoral fellow at Weill Cornell Medical Center, New York, USA and as guest professor at Federico II University, Naples, Italy. She has received many awards for her work and is a member of the Norwegian Academy for Science and Letters. She is a Fellow of the European Society of Cardiology and of the American Heart Association – Council on hypertension.

Global perspective of cardiovascular disease in women.- Obesity and cardiovascular disease in women.- Tobacco use and cardiovascular risk in women.- Nutrition, exercise and alcohol use.- Dyslipidemia in women.- Diabetes in women.- Hypertension along women’s life course.- Hypertensive cardiovascular organ damage.- Cycle abnormalities and cardiometabolic health.- Hypertensive disorders of pregnancy and cardiovascular disease risk.- Menopause and cardiovascular changes: a unique opportunity for risk assessment.- Hormone Replacement Therapy.- Migraine and Cardiovascular Risk in Women.- Rheumatic and autoimmune disorders and CVD risk in women.- Psychosocial risk in women with heart disease.- Domestic violence, psychosocial stress, socio-economic status and CVD risk in women.- Cardiovascular health issues in transgender persons.- Valvular Heart Disease in Women.- Stable ischaemic heart disease, including obstructive CAD, INOCA & coronary vasomotor disorders.- Acute coronary syndromes in Women including MINOCA.- SCAD in Acute and Chronic Phase & Work up FMD.- Atrial fibrillation in women.- Stroke in women.- Heart failure in women.- Takotsubo Syndrome.- Peripartum cardiomyopathy.- Cardiac rehabilitation in women.- Cardiotoxicity in breast cancer treatment.- Cardiovascular genetics in women.- Aortic Pathology and Peripheral Arterial Disease in Women.- Cardiovascular therapy in women with hypertension or heart failure.- Sex differences in pharmacokinetics, pharmacodynamics, and adverse drug reactions of cardiovascular drugs.